Items

• Essential to increase the use of generics in Europe to maintain comprehensive health care? (2012-01)

  B. Godman, M. Bennie, C. Baumgartel, L. Sović-Brkičić, T. Burkhardt, J. Furst, K. Garuoliene, M. Gomes, V. Marković Peković, A. Martin, C. Sermet, P. Skiold, M. van Woerkom, L. Vončina, L. Gustafsson, Essential to increase the use of generics in Europe to maintain comprehensive health care?, STED Journal, Vol. 13, No. 3S, pp. 5 - 20, Jan, 2012

• Dabigatran – a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs (2013-05)

  R. Malmstrom, E. Digene, C. Baumgartel, M. Bennie, I. Bishop, A. Brzezinska, S. Campbell, A. Ferrario, A. Finlayson, J. Furst, K. Garuoliene, M. Gomes, I. Gutierrez-Ibarluzea, A. Haycox, K. Hviding, H. Herholz, M. Hoffman, S. Jan, J. Jones, R. Joppi, M. Kalaba, C. Kvalheim, O. Laius, I. Langner, J. Lonsdale, S. Loov, K. Malinowska, L. McCullagh, K. Paterson, V. Marković Peković, A. Martin, J. Piessnegger, G. Selke, C. Sermet, S. Simoens, C. Tulnay, D. Tomek, L. Vončina, V. Vlahović-Palčevski, J. Wale, M. Wilcock, M. Wladysiuk, M. van Woerkom, C. Zara, L. Gustafsson, Dabigatran – a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs, Frontiers in Pharmacology, Vol. 4, pp. 1 - 31, May, 2013

• Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future (2016-10)

  V. Marković Peković, R. Škrbić, A. Petrović, V. Vlahović-Palčevski, J. Mrak, M. Bennie, J. Fadare, H. Kwon, K. Schiffers, I. Truter, B. Godman, Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future, Expert Review of Pharmacoeconomics & Outcomes Research , Vol. 16, No. 5, pp. 609 - 618, Oct, 2016

• Essential To Review Health Policy Initiatives When Comparing Utilisation Patterns across Countries? (2012-08)

  B. Godman, M. Bennie, S. Campbell, K. Garuoliene, M. Kalaba, V. Marković Peković, V. Vlahović-Palčevski, B. Wettermark, C. Zara, L. Gustafsson, Essential To Review Health Policy Initiatives When Comparing Utilisation Patterns across Countries?, Pharmacoepidemiology and Drug Safety Journal 2012; 21: (Suppl. 3), pp. 56 - 56, Aug, 2012